November 28, 2025

Nurix Therapeutics, Inc. (NRIX): Analyst Ratings Suggest 58% Upside Potential in Biotech Sector

Nurix Therapeutics, Inc. (NRIX) is making waves in the biotechnology sector, with promising developments in its clinical-stage pipeline and strong analyst support suggesting a notable upside for investors. This San..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Promising 76.93% Upside in the Biotech Arena

Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its ambitious focus on innovative treatments for inflammatory bowel disease (IBD). With a market..

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Unpacking a 141.78% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is gaining attention in the biotechnology sector, not only for its focus on developing gene therapies for rare diseases but also for its eye-catching potential..

Xeris Biopharma Holdings, Inc. (XERS): Investor Outlook on a Promising 60% Upside Potential

For investors seeking exposure to the dynamic world of biotechnology, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) presents a compelling opportunity. With a market capitalization of $1.19 billion, this Chicago-based firm..

Nuvation Bio Inc. (NUVB) Stock Analysis: Revenue Growth Soars with 27.97% Potential Upside

Nuvation Bio Inc. (NASDAQ: NUVB) has recently captured the attention of investors, thanks to its impressive revenue growth and a significant potential upside. With a market capitalization of $2.75 billion,..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Unveiling a 90% Potential Upside in the Biotech Sector

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors with its promising potential upside, estimated at an impressive 90.58%, according to recent analyst ratings. This Boulder, Colorado-based biopharmaceutical..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Strong Revenue Growth and Attractive Valuation Metrics

Investors scouting for opportunities in the healthcare sector may want to take a closer look at Collegium Pharmaceutical, Inc. (NASDAQ: COLL). With a market capitalization of $1.46 billion and a..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A Staggering 97.82% Potential Upside Awaits Investors

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a New York-based biotechnology company, has captured the attention of investors with its promising therapeutic developments in the oncology sector. With a market capitalization of..

Geron Corporation (GERN) Stock Analysis: Unveiling a 180% Upside Potential in Biotechnology

Investors are turning their spotlight on Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical company that promises a substantial upside potential of 180.11%, according to recent analyst ratings. Specializing in oncology..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth Amidst Challenges

Phibro Animal Health Corporation (NASDAQ: PAHC) stands at the crossroads of innovation and tradition in the healthcare sector. With a market capitalization of $1.75 billion, this American company is a..

Where wealth management meets the spotlight

For high-net-worth clients in entertainment or sport, the right banking partner must offer more than discretion, it must understand the shape of a career built on visibility...

Cooks Coffee Company reports strong HY growth and expanding store footprint

Cooks Coffee Company has reported a sharp rise in half year revenues with strong contributions from its Irish operations following the Dairygold partnership...

Valeura deepens commitment to Thai offshore assets with targeted drilling shift

Valeura’s latest offshore drilling campaign in Thailand signals a clear shift toward long-life, low-risk value creation...

Record wins a strategic foothold where currency risk meets fund complexity

Record Plc wins FX Solution of the Year, highlighting the growing strategic role of currency risk in institutional portfolios...

Mitchells & Butlers Plc reports strong FY2025 trading and profit growth

Mitchells & Butlers has delivered another year of strong performance, with like-for-like sales up 4.3 percent and adjusted operating profit rising to £330 million...

Foresight Environmental Infrastructure reports steady half year, NAV at 104.7p

Foresight Environmental Infrastructure has delivered stable first half results to 30 September 2025, reporting a NAV of 104.7p and a 2 percent NAV total return after dividends...

Sequoia Economic Infrastructure Income Fund reports strong first half NAV and income growth

Sequoia Economic Infrastructure Income Fund has reported solid half year results to 30 September 2025, with NAV rising to 93.67p and an annualised NAV total return of 10.1%...

Jubilee Metals and Galileo advance Molefe Mine development

Jubilee has entered into a project development agreement with Galileo Resources to accelerate work at the Molefe Mine in Zambia. The partnership brings together operational, processing and exploration expertise, with..

Quadrise FY25 AGM update: Project progress and commercial outlook

Quadrise plc has provided its AGM update highlighting operational progress in 2025, including trial advances, first licence revenues from Valkor and strengthened delivery capacity following its fundraise...

Real Estate Credit Investments delivers a half-year 5.9% Total NAV Return

RECI's Chairman reported a stable NAV, continued dividends of 3.0 pence per share, active portfolio management, increased loan repayments, and the launch of a further buyback programme as the Company..
Search

Funds

November 28, 2025

Where wealth management meets the spotlight

For high-net-worth clients in entertainment or sport, the right banking partner must offer more than discretion, it must understand the shape of a career built on visibility...

Cooks Coffee Company reports strong HY growth and expanding store footprint

Cooks Coffee Company has reported a sharp rise in half year revenues with strong contributions from its Irish operations following the Dairygold partnership...

Valeura deepens commitment to Thai offshore assets with targeted drilling shift

Valeura’s latest offshore drilling campaign in Thailand signals a clear shift toward long-life, low-risk value creation...

Record wins a strategic foothold where currency risk meets fund complexity

Record Plc wins FX Solution of the Year, highlighting the growing strategic role of currency risk in institutional portfolios...

Mitchells & Butlers Plc reports strong FY2025 trading and profit growth

Mitchells & Butlers has delivered another year of strong performance, with like-for-like sales up 4.3 percent and adjusted operating profit rising to £330 million...

Foresight Environmental Infrastructure reports steady half year, NAV at 104.7p

Foresight Environmental Infrastructure has delivered stable first half results to 30 September 2025, reporting a NAV of 104.7p and a 2 percent NAV total return after dividends...

Sequoia Economic Infrastructure Income Fund reports strong first half NAV and income growth

Sequoia Economic Infrastructure Income Fund has reported solid half year results to 30 September 2025, with NAV rising to 93.67p and an annualised NAV total return of 10.1%...

Jubilee Metals and Galileo advance Molefe Mine development

Jubilee has entered into a project development agreement with Galileo Resources to accelerate work at the Molefe Mine in Zambia. The partnership brings together operational, processing and exploration expertise, with Galileo funding resource definition to earn up to a 23.75 percent interest...

Quadrise FY25 AGM update: Project progress and commercial outlook

Quadrise plc has provided its AGM update highlighting operational progress in 2025, including trial advances, first licence revenues from Valkor and strengthened delivery capacity following its fundraise...

Real Estate Credit Investments delivers a half-year 5.9% Total NAV Return

RECI's Chairman reported a stable NAV, continued dividends of 3.0 pence per share, active portfolio management, increased loan repayments, and the launch of a further buyback programme as the Company focuses on disciplined deployment and shareholder value...
Search

Funds

November 28, 2025

FTSE 100

Funds